In GBM, pAKT induces overexpression of MDM2 protooncogene, which is an important negative regulator of p53 [31–33] and inhibits the apoptosis-inducing protein Bad that is inactive when phosphorylated [34]. Here, TP53 is linked to glioblastoma.